3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice

Nature Medicine

Volumn 22, Issue 9, 2016, Pages 1050-1055

  Wang, Yaoming ^a   Zhao, Zhen ^a   Rege, Sanket V ^a   Wang, Min ^a   Si, Gabriel ^a   Zhou, Yi ^b   Wang, Su ^c,d   Griffin, John H ^e,f   Goldman, Steven A ^c,d   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ACTIVATED PROTEIN C 3K3A; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; 3K3A-APC PROTEIN; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MECHANICAL STIMULATION; MOUSE; NEURAL STEM CELL; NEUROPHYSIOLOGICAL RECRUITMENT; NONHUMAN; PRIORITY JOURNAL; SENSORY STIMULATION; VOLTAGE SENSITIVE DYE IMAGING; ANIMAL; ANIMAL BEHAVIOR; BRAIN; BRAIN CORTEX; CELL PROLIFERATION; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; REGENERATION; SYNAPSE; TRANSPLANTATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN ISCHEMIA; CELL PROLIFERATION; CEREBRAL CORTEX; FLOW CYTOMETRY; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; NEURAL STEM CELLS; PROTEIN C; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; REGENERATION; SYNAPSES;

EID: 84983486427     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4154     Document Type: Article

References (43)

1. Griffin, J.H., Zlokovic, B.V. & Mosnier, L.O. Activated protein C: biased for translation. Blood 125, 2898-2907 (2015).
2. Cheng, T. et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 9, 338-342 (2003).
3. Cheng, T. et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat. Med. 12, 1278-1285 (2006).
4. Thiyagarajan, M., Fernández, J.A., Lane, S.M., Griffin, J.H. & Zlokovic, B.V. Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J. Neurosci. 28, 12788-12797 (2008).
5. Wang, Y. et al. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke 43, 2444-2449 (2012).
6. Wang, Y. et al. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats. Stroke 44, 3529-3536 (2013).
7. Walker, C.T. et al. Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact. Brain Res. 1347, 125-131 (2010).
8. Han, M.H. et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451, 1076-1081 (2008).
9. Winkler, E.A. et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl. Acad. Sci. USA 111, E1035-E1042 (2014).
10. Taylor, F.B. Jr. et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 79, 918-925 (1987).
11. Esmon, C.T. Protein C anticoagulant system - anti-inflammatory effects. Semin. Immunopathol. 34, 127-132 (2012).
12. Loubele, S.T.B.G. et al. Activated protein C protects against myocardial ischemia/reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler. Thromb. Vasc. Biol. 29, 1087-1092 (2009).
13. Park, S.W., Chen, S.W.C., Kim, M., D'Agati, V.D. & Lee, H.T. Human activated protein C attenuates both hepatic and renal injury caused by hepatic ischemia and reperfusion injury in mice. Kidney Int. 76, 739-750 (2009).
14. Isermann, B. et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 13, 1349-1358 (2007).
15. Geiger, H. et al. Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity. Nat. Med. 18, 1123-1129 (2012).
16. Lyden, P. et al. Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr. Pharm. Des. 19, 7479-7485 (2013).
17. Safety evaluation of 3K3A-APC in ischemic stroke (RHAPSODY); 2014 August 18; https://clinicaltrials.gov/ct2/show/NCT02222714.
18. Wang, S. et al. Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting. J. Neurosci. 30, 14635-14648 (2010).
19. Guo, H. et al. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. J. Neurosci. 33, 6181-6190 (2013).
20. Savitz, S.I. Cell therapies: careful translation from animals to patients. Stroke 44 (Suppl. 1), S107-S109 (2013).
21. Keyoung, H.M. et al. High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Nat. Biotechnol. 19, 843-850 (2001).
22. Albers, G.W. et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 42, 2645-2650 (2011).
23. Kelly, S. et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. USA 101, 11839-11844 (2004).
24. Taguchi, A. et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330-338 (2004).
25. Zhao, B.-Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445 (2006).
26. Wen, Z. & Wang, P. Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke. Neural Regen. Res. 7, 578-582 (2012).
27. Wang, Y. et al. Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1. Brain Res. 1507, 97-104 (2013).
28. Abematsu, M. et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J. Clin. Invest. 120, 3255-3266 (2010).
29. Tian, L. et al. Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat. Methods 6, 875-881 (2009).
30. Vanni, M.P. & Murphy, T.H. Mesoscale transcranial spontaneous activity mapping in GCaMP3 transgenic mice reveals extensive reciprocal connections between areas of somatomotor cortex. J. Neurosci. 34, 15931-15946 (2014).
31. Zariwala, H.A. et al. A Cre-dependent GCaMP3 reporter mouse for neuronal imaging in vivo. J. Neurosci. 32, 3131-3141 (2012).
32. Li, D., Agulhon, C., Schmidt, E., Oheim, M. & Ropert, N. New tools for investigating astrocyte-to-neuron communication. Front. Cell. Neurosci. 7, 193 (2013).
33. Horie, N. et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29, 274-285 (2011).
34. Wurmser, A.E. et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430, 350-356 (2004).
35. Goldman, S.A. Stem and progenitor cell-based therapy of the central nervous system: hopes, hype, and wishful thinking. Cell Stem Cell 18, 174-188 (2016).
36. Fuchs, E.J. Transplantation tolerance: from theory to clinic. Immunol. Rev. 258, 64-79 (2014).
37. Markgraf, C.G. et al. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke 25, 153-159 (1994).
38. Williams, P.D. et al. Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated Protein C for ischemic stroke. Curr. Pharm. Des. 18, 4215-4222 (2012).
39. Bouet, V. et al. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 4, 1560-1564 (2009).
40. Freret, T. et al. Behavioral deficits after distal focal cerebral ischemia in mice: Usefulness of adhesive removal test. Behav. Neurosci. 123, 224-230 (2009).
41. Furukawa, N., Saito, M., Hakoshima, T. & Kohno, K. A diphtheria toxin receptor deficient in epidermal growth factor-like biological activity. J. Biochem. 140, 831-841 (2006).
42. Saito, M. et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746-750 (2001).
43. Ullian, E.M., Sapperstein, S.K., Christopherson, K.S. & Barres, B.A. Control of synapse number by glia. Science 291, 657-661 (2001).